Our trusted team of thought leaders provides the latest insights and perspectives on important health industry and management consulting trends and topics.
Vynamic partnered with a top Life Sciences client for a multi-year omnichannel transformation, enhancing customer experience.
Medical Affairs is both a rewarding and challenging area in the evolving environment of drug development and launch readiness planning.
Medical affairs plays a critical role in key activities for pharmaceutical companies. This includes evidence generation, evidence dissemination.
A global pharmaceutical company based in Europe needed to ensure robust and consistent product launch execution by Medical Affairs teams.
The US medical leadership team of a global life sciences company was faced with competing objectives based on changes in leadership.
Only 10% of pharma’s patient programs measure the patient experience.
A Global Medical Affairs infectious disease team wanted to understand and leverage key learnings from Disease Awareness pre-launch/launch.
Vynamic mapped the internal organization across functions and roles into a RACI with senior management buy-in.
Vynamic conducted in-depth benchmarking interviews with Medical Affairs executives from eight top-tier pharmaceutical companies across the industry.
Vynamic conducted in-depth surveys to identify institutional, attitudinal, and functional preferences to enable multiple potential segmentation.
Vynamic partnered with client core team representatives to first identify all stakeholders, single points of contact, and any gaps in operating model.
Vynamic leveraged deep expertise in organizational change to create a business case for a new model in Medical Affairs and identified a core team.
